The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
In Novo Nordisk's studies, patients taking the drug maintained weight loss after four years and were helped by its heart health benefits, which could strengthen the case for insurers to cover the cost of Wegovy.
Prescription drug ads will soon look different as new federal transparency rules take effect, requiring commercials to clearly spell out potential side effects, essentially ending those rapid-fire disclaimers at the end of many commercials.
Up to four years after the onset of the disability, 39% of potential Social Security disability insurance applicants had submitted a claim in non-mandate states.
A group of Republican lawmakers urged the Education Department in a letter to nix its grand-scale bailout, which would provide even greater student debt relief than an earlier attempt struck down by the Supreme Court.
As the drugmaker moves into Phase III studies for survodutide, its new GLP-1 obesity drug, Walgreens will use its community pharmacies as clinical trial sites, aiming to improve access and address equitable health representation.